Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.

MLA

Pratcorona, Maria, et al. “Favorable Outcome of Patients with Acute Myeloid Leukemia Harboring a Low-Allelic Burden FLT3-ITD Mutation and Concomitant NPM1 Mutation: Relevance to Post-Remission Therapy.” Blood, vol. 121, no. 14, Apr. 2013, pp. 2734–38. EBSCOhost, https://doi.org/10.1182/blood-2012-06-431122.

APA

Pratcorona, M., Brunet, S., Nomdedéu, J., Maria Ribera, J., Tormo, M., Duarte, R., Escoda, L., Guàrdia, R., Paz Queipo de Llano, M., Salamero, O., Bargay, J., Pedro, C., Maria Marti, J., Torrebadell, M., Díaz-Beyá, M., Camós, M., Colomer, D., Hoyos, M., Sierra, J., & Esteve, J. (2013). Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. Blood, 121(14), 2734–2738. https://doi.org/10.1182/blood-2012-06-431122

Chicago

Pratcorona, Maria, Salut Brunet, Josep Nomdedéu, Josep Maria Ribera, Mar Tormo, Rafael Duarte, Lourdes Escoda, et al. 2013. “Favorable Outcome of Patients with Acute Myeloid Leukemia Harboring a Low-Allelic Burden FLT3-ITD Mutation and Concomitant NPM1 Mutation: Relevance to Post-Remission Therapy.” Blood 121 (14): 2734–38. doi:10.1182/blood-2012-06-431122.